Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

NCT00807573 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: Paclitaxel
DRUG: Pemetrexed
DRUG: Bevacizumab

Sponsor

Memorial Sloan Kettering Cancer Center